U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Arcutis Biotherapeutics

Market Cap: US$1.8b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Exact Sciences

Market Cap: US$7.8b

Provides cancer screening and diagnostic test products in the United States and internationally.

Merck

Market Cap: US$201.5b

Operates as a healthcare company worldwide.

CorMedix

Market Cap: US$771.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Catalyst Pharmaceuticals

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Regeneron Pharmaceuticals

Market Cap: US$58.4b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Jazz Pharmaceuticals

Market Cap: US$6.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Decibel Cannabis

Market Cap: US$60.6m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Teva Pharmaceutical Industries

Market Cap: US$18.8b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

BeOne Medicines

Market Cap: US$31.7b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ICON

Market Cap: US$12.3b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Evolus

Market Cap: US$381.6m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Sanofi

Market Cap: US$99.2b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Perrigo

Market Cap: US$3.1b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Amneal Pharmaceuticals

Market Cap: US$2.7b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Cresco Labs

Market Cap: US$452.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Bayer

Market Cap: US$25.3b

Operates as a life science company worldwide.

Curaleaf Holdings

Market Cap: US$2.1b

Produces and distributes cannabis products in the United States and internationally.

Trulieve Cannabis

Market Cap: US$1.5b

Operates as a cannabis retailer.

Royalty Pharma

Market Cap: US$21.9b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Pacira BioSciences

Market Cap: US$1.1b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Viatris

Market Cap: US$11.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Avantor

Market Cap: US$7.8b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Evotec

Market Cap: US$1.2b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Merck KGaA

Market Cap: US$47.0b

Operates as a science and technology company in Germany.

AVITA Medical

Market Cap: US$112.9m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Organon

Market Cap: US$2.4b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Biogen

Market Cap: US$19.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Amphastar Pharmaceuticals

Market Cap: US$1.3b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Halozyme Therapeutics

Market Cap: US$7.4b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Tilray Brands

Market Cap: US$712.6m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Sarepta Therapeutics

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Shionogi

Market Cap: US$2.2t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Pharming Group

Market Cap: US$696.1m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Puma Biotechnology

Market Cap: US$185.9m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Bayer

Market Cap: US$25.3b

Operates as a life science company worldwide.